Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Apoptosis

High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment

Leukemia volume 17, pages 576–584 (2003)Cite this article

Abstract

In this study, we analyzed the influence of cell cycle status manipulations of leukemic cells on Fas-mediated apoptosis using the GM-CSF-dependent human myeloid leukemia cell line AML-193 as a model. GM-CSF and long-term treatment with interferon-gamma (IFN-γ) or interferon-alpha (IFN-α) were used to manipulate the cell cycle status. Control cells were GM-CSF deprived, nonproliferating cells. IFN-γ or IFN-α treatment did not induce proliferation in control cells, but resulted in recruitment of cells from resting G0 phase into activated G1 phase. Using agonistic anti-Fas antibodies (FAS18), we demonstrated that this shift from G0 to G1 was accompanied by a 2.5-fold increase in Fas sensitivity. A similar increase in sensitivity to FAS18 could be obtained by induction of proliferation with GM-CSF. Quantitative FACS analysis of surviving cells after FAS18-induced apoptosis showed deletion of the G1 compartment, but complete protection of resting G0 cells. Cells in S or G2/M phase were relatively protected against Fas induction. In conclusion, sensitivity to Fas-mediated apoptosis was restricted to cells in G1 phase of the cell cycle, and can be increased by treatment of cells with interferons. By this mechanism, interferon treatment may render leukemic cells more susceptible to lysis by T cells during immunotherapeutic interventions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Liliemark JO, Plunkett W . Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5′-triphosphate. Cancer Res 1986; 46: 1079–1083.

    CAS  PubMed  Google Scholar 

  2. van Maanen JM, Retel J, de Vries J, Pinedo HM . Mechanism of action of antitumor drug etoposide: a review. J Natl Cancer Inst 1988; 80: 1526–1533.

    Article  CAS  PubMed  Google Scholar 

  3. Helg C, Starobinski M, Jeannet M, Chapuis B . Donor lymphocyte infusion for the treatment of relapse after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 1998; 29: 301–313.

    Article  CAS  PubMed  Google Scholar 

  4. Smit WM, Rijnbeek M, van Bergen CA, Fibbe WE, Willemze R, Falkenburg JH . T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proc Natl Acad Sci USA 1998; 95: 10152–10157.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Falkenburg JHF, Wafelman AR, Joosten P, Smit WM, van Bergen CAM, Bongaerts R et al. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 1999; 94: 1201–1208.

    CAS  PubMed  Google Scholar 

  6. Waring P, Mullbacher A . Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 1999; 77: 312–317.

    Article  CAS  PubMed  Google Scholar 

  7. Ashkenazi A, Dixit VM . Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255–260.

    Article  CAS  PubMed  Google Scholar 

  8. Nagata S . Apoptosis by death factor. Cell 1997; 88: 355–365.

    Article  CAS  PubMed  Google Scholar 

  9. Komada Y, Zhou YW, Zhang XL, Xue HL, Sakai H, Tanaka S et al. Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 1995; 86: 3848–3860.

    CAS  PubMed  Google Scholar 

  10. Beletskaya IV, Nikonova LV, Beletsky IP . Cell cycle specificity of Fas-mediated apoptosis in WIL-2 cells. FEBS Lett 1997; 412: 91–93.

    Article  CAS  PubMed  Google Scholar 

  11. Hueber A, Durka S, Weller M . CD95-mediated apoptosis: no variation in cellular sensitivity during cell cycle progression. FEBS Lett 1998; 432: 155–157.

    Article  CAS  PubMed  Google Scholar 

  12. Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 1987; 70: 192–199.

    CAS  PubMed  Google Scholar 

  13. Jonasch E, Haluska FG . Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 2001; 6: 34–55.

    Article  CAS  PubMed  Google Scholar 

  14. Ezaki K . Cytokine therapy for hematological malignancies. Int J Hematol 1996; 65: 17–29.

    Article  CAS  PubMed  Google Scholar 

  15. Leda M, Ladon D, Pieczonka A, Boruczkowski D, Jolkowska J, Witt M et al. Donor lymphocyte infusion followed by interferon-alpha plus low dose cyclosporine A for modulation of donor CD3 cells activity with monitoring of minimal residual disease and cellular chimerism in a patient with first hematologic relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res 2001; 25: 353–357.

    Article  CAS  PubMed  Google Scholar 

  16. Marijt WAF, Barge RMY, Fibbe WE . Combining alpha-interferon with low dose donor lymphocyte infusion (DLI) for relapsed CML reduces the interval between DLI and complete remission (CR) and is associated with limited GVHD. Blood 2000; 96: 196a (Abstract).

    Google Scholar 

  17. Spets H, Georgii-Hemming P, Siljason J, Nilsson K, Jernberg-Wiklund H . Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon-alpha in interleukin-6 (IL-6)-dependent and IL-6 independent multiple myeloma cell lines. Blood 1998; 92: 2914–2923.

    CAS  PubMed  Google Scholar 

  18. Zella D, Barabitskaja O, Casareto L, Romerio F, Secchiero P, Reitz Jr MS et al. Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells. J Immunol 1999; 163: 3169–3175.

    CAS  PubMed  Google Scholar 

  19. Ruiz-Ruiz C, Munoz-Pinedo C, Lopez-Rivas A . Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program. Cancer Res 2000; 60: 5673–5680.

    CAS  PubMed  Google Scholar 

  20. Jordan CT, Yamasaki G, Minamoto D . High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations. Exp Hematol 1996; 24: 1347–1355.

    CAS  PubMed  Google Scholar 

  21. van Oijen MG, Medema RH, Slootweg PJ, Rijksen G . Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 1998; 110: 24–31.

    Article  CAS  PubMed  Google Scholar 

  22. Danova M, Riccardi A, Mazzini G . Cell cycle-related proteins and flow cytometry. Haematologica 1990; 75: 252–264.

    CAS  PubMed  Google Scholar 

  23. Landberg G, Tan EM, Roos G . Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp Cell Res 1990; 187: 111–118.

    Article  CAS  PubMed  Google Scholar 

  24. Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H . Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 1986; 90: 65–70.

    Article  CAS  PubMed  Google Scholar 

  25. Barge RM, Willemze R, Vandenabeele P, Fiers W, Beyaert R . Differential involvement of caspases in apoptosis of myeloid leukemic cells induced by chemotherapy versus growth factor withdrawal. FEBS Lett 1997; 409: 207–210.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Laboratory of Experimental Hematology, Leiden University Medical Center, The Netherlands

    I Jedema, R M Y Barge, R Willemze & J H F Falkenburg

Authors
  1. I Jedema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R M Y Barge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Willemze
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J H F Falkenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jedema, I., Barge, R., Willemze, R. et al. High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment. Leukemia 17, 576–584 (2003). https://doi.org/10.1038/sj.leu.2402844

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402844

Keywords

This article is cited by

Search

Advanced search

Quick links